Global Antibiotics Market, as forecasted by BCC Research,
to Grow at a Compound Annual Growth Rate (CAGR) of 4.2% Through
2027
BOSTON, May 22, 2024
/PRNewswire/ -- According to the latest BCC Research study,
the demand for Antibiotics: Technologies and Global Markets
should reach $49.6 billion by 2027,
with a compound annual growth rate (CAGR) of 4.2%.
This report covers the latest progress in chemical compounds and
the latest drugs, except those aimed at control of the vector or
symptomatic treatment. It emphasizes antibiotics, tests their
market potential, segmentation of competition landscapes and
markets based on the type of product (such as cell wall inhibitors,
protein inhibitors, DNA, and other inhibitors), administrative
pathways (oral and topical), and geographical regions (including
North America, Europe, Asia-Pacific, South
America, and the Middle
East and Africa). The
analysis covers key countries in these regions and provides insight
into market dynamics, pricing, the impact of COVID-19, and the
regulatory environment. Market forecasts till 2027 and market share
assessment of key players deepen the report and provide
pharmaceutical industry stakeholders with a comprehensive view.
Antibiotic resistance is a growing problem worldwide, causing
over 1.27 million deaths annually and costing the U.S. $4.6 billion each year. From 2000 to 2018,
antibiotic use surged by 46%, especially in regions like
North Africa, the Middle East, and South Asia. The COVID-19 pandemic worsened the
situation, with antibiotics often misused to treat the virus. This
highlights the urgent need for better stewardship and innovative
approaches to tackle antibiotic resistance globally.
To learn more about "Antibiotics: Technology and Global Market
Report", please click here for more information.
Key Drivers of the Antibiotics: Technologies and Global
Markets
Growth Driven by Antibiotics: The global demand for
antibiotics is rising due to their essential role in treating
bacterial infections across various medical sectors. Factors such
as increasing infectious disease prevalence, drug-resistant
bacteria emergence, and pharmaceutical research investment drive
this growth.
Rising Elder Population and Infection Rate: As the global
population ages, there is a surge in infections among the elderly
due to weakened immune systems. This demographic trend boosts the
need for antibiotics to manage age-related health
conditions.
Increasing Hospital-acquired Infections:
Hospital-acquired infections (HAIs) are a significant concern,
driving demand for antibiotics to treat and prevent their spread
within healthcare facilities.
Improved Awareness: Greater awareness about responsible
antibiotic use among healthcare professionals and the public
promotes sustainable usage and combats antibiotic resistance.
Request a Sample Copy of the Antibiotics:
Technologies and Global Markets Report.
Report Synopsis
Report Metrics
|
Details
|
Base year
considered
|
2021s
|
Forecast Period
considered
|
2022-2027
|
Base year market
size
|
$10.4
billion
|
Market Size
Forecast
|
$19.5
billion
|
Growth Rate
|
CAGR of 11.0% for the
forecast period of 2023-2028
|
Segment
Covered
|
Product, Route of
Administration
|
Regions
covered
|
North America, Europe,
Asia-Pacific, Latin America, Middle East and Africa
|
Countries
covered
|
U.S., Canada, Mexico,
Germany, France, UK, Italy, Spain, Switzerland, Denmark, Norway,
Poland, Belgium, Austria, the Netherlands, Sweden, Russia, Japan,
China, India, Australia, New Zealand, Taiwan, Singapore, Malaysia,
Thailand, Philippines, Korea, Indonesia, Brazil, Argentina, Chile,
Colombia, Peru, GCC countries, South Africa, Tukey, Egypt, Nigeria,
Kenya
|
Key Market
Drivers
|
- Growth Driven by
Antibiotics
- Rising Elder
Population and Infection Rate
- Increasing
Hospital-acquired Infections
- Improved
Awareness
|
Segmentation Analysis:
Product Types Segmentation
Analysis:
- Cell Wall Inhibitors: These antibiotics disrupt
bacterial cell walls, stopping bacterial growth. Examples:
penicillins, cephalosporins, glycopeptides (e.g., vancomycin).
- Protein Inhibitors: They interfere with bacterial
protein synthesis, hindering their function. Examples:
tetracyclines, macrolides (e.g., erythromycin), aminoglycosides
(e.g., gentamicin).
- DNA Inhibitors: These antibiotics disrupt bacterial DNA
processes, hampering survival. Examples: fluoroquinolones (e.g.,
ciprofloxacin), sulfonamides.
- Other Types of Inhibitors: Unique mechanisms include
inhibiting RNA synthesis or metabolic pathways. Examples:
linezolid, and trimethoprim.
Routes of Administration Segmentation
Analysis:
- Oral Antibiotics: Taken by mouth for mild to moderate
infections. Examples: amoxicillin, doxycycline, azithromycin.
- Topical Antibiotics: Applied to skin or mucous membranes
for localized infections. Examples: antibiotic creams, ointments,
and eye drops.
- Other Routes: Includes IV administration for severe
infections or when oral is not feasible.
This Antibiotics: Technologies and Global
Markets Report contains comprehensive information and analysis
covering the following key questions:
- What is the projected market size and growth rate of the
Antibiotics Market?
The antibiotics market is projected to grow from $39.2 million in 2021 to $49.6 million in 2027, at a compound annual
growth rate (CAGR) of 4.2% during the forecast period.
- What are the key factors driving the growth of the Antibiotics
Market?
The key factors driving the growth of the antibiotics market are,
the rise of infectious diseases, increasing awareness due to COVID
and new antibiotics being launched and researched on.
- What segments are covered in the Antibiotics market?
The antibiotics market is segmented on basis of type, Cell Wall
inhibitor, Protein Inhibitors, DNA inhibitors and other types.
Also, regional segmentation is provided.
- By Type, which segment will dominate the market by the end of
2027?
The cell wall inhibitors will lead the market by 2027.
- Which region has the highest market share in the Antibiotics
Market?
North America holds the highest
share of the market.
Some of the Key Market Players Are:
- ABBOTT
- F. HOFFMANN-LA ROCHE LTD.
- GSK PLC.
- JOHNSON & JOHNSON SERVICES INC.
- MERCK & CO. INC.
- PFIZER INC.
- SANOFI
- VIATRIS INC.
Directly Purchase a copy of the
report with BCC Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16,
Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit
our media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/global-antibiotics-market-projected-to-reach-49-6-billion-by-2027--302152568.html
SOURCE BCC Research LLC